These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33894637)

  • 21. Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates.
    Andrews PC; Frank R; Junk PC; Kedzierski L; Kumar I; MacLellan JG
    J Inorg Biochem; 2011 Mar; 105(3):454-61. PubMed ID: 20851471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, properties and structures of the first series of organometallic Pt(II) and Pt(IV) complexes with stibine co-ligands.
    Brown MD; Levason W; Reid G; Webster M
    Dalton Trans; 2006 Apr; (13):1667-74. PubMed ID: 16547542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complexation of antimony (Sb(V)) with guanosine 5'-monophosphate and guanosine 5'-diphospho-D-mannose: formation of both mono- and bis-adducts.
    Chai Y; Yan S; Wong IL; Chow LM; Sun H
    J Inorg Biochem; 2005 Dec; 99(12):2257-63. PubMed ID: 16214217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages.
    Islam A; Da Silva JG; Berbet FM; da Silva SM; Rodrigues BL; Beraldo H; Melo MN; Frézard F; Demicheli C
    Molecules; 2014 May; 19(5):6009-30. PubMed ID: 24824136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, crystal structure and leishmanicidal activity of new trimethoprim Ru(III), Cu(II) and Pt(II) metal complexes.
    Silva GL; Dias JSM; Silva HVR; Teixeira JDS; De Souza IRB; Guimarães ET; de Magalhães Moreira DR; Soares MBP; Barbosa MIF; Doriguetto AC
    J Inorg Biochem; 2020 Apr; 205():111002. PubMed ID: 32007697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani.
    Shaked-Mishan P; Ulrich N; Ephros M; Zilberstein D
    J Biol Chem; 2001 Feb; 276(6):3971-6. PubMed ID: 11110784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syntheses, crystal structures and antimicrobial activities of 6-coordinate antimony(III) complexes with tridentate 2-acetylpyridine thiosemicarbazone, bis(thiosemicarbazone) and semicarbazone ligands.
    Kasuga NC; Onodera K; Nakano S; Hayashi K; Nomiya K
    J Inorg Biochem; 2006 Jul; 100(7):1176-86. PubMed ID: 16546259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urease inhibition and anti-leishmanial assay of substituted benzoylguanidines and their copper(II) complexes.
    Murtaza G; Badshah A; Said M; Khan H; Khan A; Khan S; Siddiq S; Choudhary MI; Boudreau J; Fontaine FG
    Dalton Trans; 2011 Sep; 40(36):9202-11. PubMed ID: 21829831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmanicidal activity of polysaccharides and their oxovanadium(IV/V) complexes.
    do Amaral AE; Petkowicz CL; Mercê AL; Iacomini M; Martinez GR; Merlin Rocha ME; Cadena SM; Noleto GR
    Eur J Med Chem; 2015 Jan; 90():732-41. PubMed ID: 25506811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural motifs and biological studies of new antimony(III) iodide complexes with thiones.
    Ozturk I; Filimonova S; Hadjikakou SK; Kourkoumelis N; Dokorou V; Manos MJ; Tasiopoulos AJ; Barsan MM; Butler IS; Milaeva ER; Balzarini J; Hadjiliadis N
    Inorg Chem; 2010 Jan; 49(2):488-501. PubMed ID: 20000436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
    Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
    Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pt-Fe ferrocenyl compounds with hydroxyquinoline ligands show selective cytotoxicity on highly proliferative cells.
    Rivas F; Medeiros A; Comini M; Suescun L; Rodríguez Arce E; Martins M; Pinheiro T; Marques F; Gambino D
    J Inorg Biochem; 2019 Oct; 199():110779. PubMed ID: 31351379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polarity-sensitive nanocarrier for oral delivery of Sb(V) and treatment of cutaneous leishmaniasis.
    Lanza JS; Fernandes FR; Corrêa-Júnior JD; Vilela JM; Magalhães-Paniago R; Ferreira LA; Andrade MS; Demicheli C; Melo MN; Frézard F
    Int J Nanomedicine; 2016; 11():2305-18. PubMed ID: 27307731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High antitumor activity of 5,7-dihalo-8-quinolinolato tin(IV) complexes.
    Chen ZF; Peng Y; Gu YQ; Liu YC; Liu M; Huang KB; Hu K; Liang H
    Eur J Med Chem; 2013 Apr; 62():51-8. PubMed ID: 23353732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity.
    Borborema SE; Osso Junior JA; Andrade Junior HF; Nascimento Nd
    Rev Soc Bras Med Trop; 2016 Apr; 49(2):196-203. PubMed ID: 27192589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
    Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
    ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio)semicarbazides as a novel class of anti-leishmanial agents.
    Eldehna WM; Almahli H; Ibrahim TM; Fares M; Al-Warhi T; Boeckler FM; Bekhit AA; Abdel-Aziz HA
    Eur J Med Chem; 2019 Oct; 179():335-346. PubMed ID: 31260888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimony(III) complexes with 2-benzoylpyridine-derived thiosemicarbazones: cytotoxicity against human leukemia cell lines.
    Reis DC; Pinto MC; Souza-Fagundes EM; Wardell SM; Wardell JL; Beraldo H
    Eur J Med Chem; 2010 Sep; 45(9):3904-10. PubMed ID: 20576328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.
    Andrews PC; Blair VL; Ferrero RL; Junk PC; Kedzierski L; Peiris RM
    Dalton Trans; 2014 Jan; 43(3):1279-91. PubMed ID: 24190067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Thiophene Compounds as Potent Chemotherapies for the Treatment of Cutaneous Leishmaniasis Caused by
    Rodriguez F; Iniguez E; Pena Contreras G; Ahmed H; Costa TEMM; Skouta R; Maldonado RA
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29973498
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.